My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 207

    1.

    The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells.

    Shapira M, Kakiashvili E, Rosenberg T, Hershko DD.

    Breast Cancer Res. 2006;8(4):R46.PMID: 16859513 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The expression of the ubiquitin ligase subunit Cks1 in human breast cancer.

    Slotky M, Shapira M, Ben-Izhak O, Linn S, Futerman B, Tsalic M, Hershko DD.

    Breast Cancer Res. 2005;7(5):R737-44. Epub 2005 Jul 19.PMID: 16168119 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.

    Huang HC, Way TD, Lin CL, Lin JK.

    Endocrinology. 2008 Dec;149(12):5972-83. Epub 2008 Aug 21.PMID: 18719023 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells.

    Bar-On O, Shapira M, Hershko DD.

    Anticancer Drugs. 2007 Nov;18(10):1113-21.PMID: 17893511 [PubMed - indexed for MEDLINE]Related articles

    6.

    The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells.

    Lu L, Schulz H, Wolf DA.

    BMC Cell Biol. 2002 Aug 20;3:22. Epub 2002 Aug 20.PMID: 12188931 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.

    Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M.

    Nature. 2004 Mar 11;428(6979):190-3.PMID: 15014502 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.

    Lwin T, Hazlehurst LA, Dessureault S, Lai R, Bai W, Sotomayor E, Moscinski LC, Dalton WS, Tao J.

    Blood. 2007 Sep 1;110(5):1631-8. Epub 2007 May 14.PMID: 17502456 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway.

    Foster JS, Fernando RI, Ishida N, Nakayama KI, Wimalasena J.

    J Biol Chem. 2003 Oct 17;278(42):41355-66. Epub 2003 Aug 6.PMID: 12904306 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in early esophageal squamous cell carcinoma.

    Fukuchi M, Masuda N, Nakajima M, Fukai Y, Miyazaki T, Kato H, Kuwano H.

    Anticancer Res. 2004 Mar-Apr;24(2B):777-83.PMID: 15161026 [PubMed - indexed for MEDLINE]Related articles

    11.

    Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.

    Shibahara T, Onishi T, Franco OE, Arima K, Sugimura Y.

    Anticancer Res. 2005 May-Jun;25(3B):1881-8.PMID: 16158921 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition.

    Liu W, Wu G, Li W, Lobur D, Wan Y.

    Mol Cell Biol. 2007 Apr;27(8):2967-79. Epub 2007 Feb 5.PMID: 17283060 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.

    Calvisi DF, Ladu S, Pinna F, Frau M, Tomasi ML, Sini M, Simile MM, Bonelli P, Muroni MR, Seddaiu MA, Lim DS, Feo F, Pascale RM.

    Gastroenterology. 2009 Nov;137(5):1816-26.e1-10. Epub 2009 Aug 15.PMID: 19686743 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells.

    García-Morales P, Hernando E, Carrasco-García E, Menéndez-Gutierrez MP, Saceda M, Martínez-Lacaci I.

    Mol Cancer Ther. 2006 Sep;5(9):2172-81.PMID: 16985050 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Skp2 regulates G2/M progression in a p53-dependent manner.

    Hu R, Aplin AE.

    Mol Biol Cell. 2008 Nov;19(11):4602-10. Epub 2008 Aug 20.PMID: 18716061 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Regulation of Skp2-p27 axis by the Cdh1/anaphase-promoting complex pathway in colorectal tumorigenesis.

    Fujita T, Liu W, Doihara H, Wan Y.

    Am J Pathol. 2008 Jul;173(1):217-28. Epub 2008 Jun 5.PMID: 18535175 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.

    Bhatt KV, Hu R, Spofford LS, Aplin AE.

    Oncogene. 2007 Feb 15;26(7):1056-66. Epub 2006 Aug 21.PMID: 16924241 [PubMed - indexed for MEDLINE]Related articles

    19.

    Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas.

    Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM, Hershko A.

    Cancer. 2001 May 1;91(9):1745-51.PMID: 11335900 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.

    Auld CA, Fernandes KM, Morrison RF.

    J Cell Physiol. 2007 Apr;211(1):101-11.PMID: 17096381 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk